EUVIMEDEUVIMED entdecken
Crossref

Dual-Targeted Self-Adjuvant Heterocyclic Lipidoid@Polyester Hybrid Nanovaccines for Boosting Cancer Immunotherapy

Zixu Liu, Boyuan Liu, Yupeng Feng, Linxuan Zhao, Qingqing Wang, Haibing He iD, Tian Yin, Yu Zhang iD, Li Yang, Jingxin Gou, Xing Tang iD

ACS Nano · 2024

DOI: 10.1021/acsnano.4c00392 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, 2024. Verfasst von Zixu Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics Science, Shenyang Pharmaceutical University, Shenyang 110116, China. Hauptthemen laut MEDLINE: Cancer Vaccines, Immunotherapy, Polyesters, Nanoparticles. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Liaoning Livelihood Science and Technology Plan Joint Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer VaccinesImmunotherapyPolyestersNanoparticlesAnimalsMiceMice, Inbred C57BLTumor MicroenvironmentDendritic CellsFemaleAdjuvants, ImmunologicLipidsHumansNeoplasmsCell Line, TumorRNA, Small InterferingHyaluronic AcidNanovaccines

Stichwörter der Autor:innen

STAT3 siRNASTING pathwaydual-targetedimmune checkpoint blockadenanovaccinestumor-associated neutrophils

Substanzen

Cancer VaccinesPolyestersAdjuvants, ImmunologicLipidsRNA, Small InterferingHyaluronic AcidNanovaccines

Autor:innen und Institutionen

  • Department of Pharmaceutics Science, Shenyang Pharmaceutical University, Shenyang 110116, China.
  • Department of Pharmaceutics, College of Pharmacy Sciences, Jilin University, Changchun 130021, China.
  • School of Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang 110016, China.

ORCID-Profile: Haibing He, Yu Zhang, Xing Tang

Förderung

  • National Key Research and Development Program of China
  • Liaoning Livelihood Science and Technology Plan Joint Project

Zitieren

APA

Liu, Z., Liu, B., Feng, Y., Zhao, L., Wang, Q., He, H., Yin, T., Zhang, Y., Yang, L., Gou, J., & Tang, X. (2024). Dual-Targeted Self-Adjuvant Heterocyclic Lipidoid@Polyester Hybrid Nanovaccines for Boosting Cancer Immunotherapy. ACS Nano. https://doi.org/10.1021/acsnano.4c00392

Vancouver

Liu Z, Liu B, Feng Y, Zhao L, Wang Q, He H, et al. Dual-Targeted Self-Adjuvant Heterocyclic Lipidoid@Polyester Hybrid Nanovaccines for Boosting Cancer Immunotherapy. ACS Nano. 2024. doi:10.1021/acsnano.4c00392

BibTeX
@article{Liu2024,
  author = {Liu, Zixu and Liu, Boyuan and Feng, Yupeng and Zhao, Linxuan and Wang, Qingqing and He, Haibing and Yin, Tian and Zhang, Yu and Yang, Li and Gou, Jingxin and Tang, Xing},
  title = {Dual-Targeted Self-Adjuvant Heterocyclic Lipidoid@Polyester Hybrid Nanovaccines for Boosting Cancer Immunotherapy},
  journal = {ACS Nano},
  year = {2024},
  doi = {10.1021/acsnano.4c00392}
}
Kostenlos starten →